Lutris Pharma Appoints Life Sciences and Pharmaceutical Entrepreneur Moshe “Mori” Arkin to Its Board of Directors

Posted on by

TEL AVIV, Israel, April 1, 2024 /PRNewswire/ — Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing dose limiting side effects, today announced the appointment Moshe “Mori” Arkin, a life sciences and pharmaceutical entrepreneur,…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.